Comparison of Busulfan and Cyclophosphamide (Bu-Cy)-Based Standard Myeloablative Conditioning (MAC) Vs. Fludarabine and Busulfan (Flu-Bu)-Based Reduced-Intensity Conditioning (RIC) Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) Patients in First Complete Remission (CR1) Aged >40 Years: a Retrospective Analysis From the Acute Leukemia Working Party of EBMT

被引：5
|
作者：
Mohty, Mohamad [1 ]
Labopin, Myriam [2 ,3 ]
Socie, Gerard [4 ]
Milpied, Noel-Jean [5 ]
Attal, Michel [6 ]
Blaise, Didier [7 ]
Ringden, Olle [8 ]
Brown, Paul [9 ]
Lorentz, Brinch [10 ]
Brune, Mats L. [11 ]
Hamladji, Rose-Marie [12 ]
Duarte, Rafael F. [13 ]
Nagler, Arnon [14 ]
Rocha, Vanderson [15 ,16 ]
机构：
[1] CHU Nantes, Dept Hematol, F-44035 Nantes 01, France
[2] Hop St Antoine, F-75571 Paris, France
[3] Univ Paris 06, EBMT ALWP Off, F-75571 Paris, France
[4] Serv Greffe Moelle, Paris, France
[5] CHU Bordeaux, Bordeaux, France
[6] Univ Hosp, CHU Dept Hematol, Toulouse, France
[7] Inst J Paoli I Calmettes, F-13009 Marseille, France
[8] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden
[9] St James Hosp, Trinity Coll, Dublin 8, Ireland
[10] Univ Oslo, Rikshosp, N-0027 Oslo, Norway
[11] Sahlgrens Univ Hosp, Ctr Hematopoiet Cell Transplantat, Gothenburg, Sweden
[12] Pierre & Marie Curie Ctr, Serv Hematol Greffe de Moelle, Algiers, Algeria
[13] Inst Catalan Oncol, Barcelona, Spain
[14] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel
[15] Hop St Louis, APHP, BMT Unit, EBMT ALWP, Paris, France
[16] Univ Paris 07, Paris, France
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.4030.4030
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1306 / 1306
页数：1
相关论文
共 23 条
  • [11] THIOTEPA-BASED VS TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT
    Eder, S.
    Labopin, M.
    Arcese, W.
    Or, R.
    Majolino, I.
    Bacigalupo, A.
    de Rosa, G.
    Volin, L.
    Beelen, D.
    Veelken, H.
    Schaap, N. P.
    Kuball, J.
    Cornelissen, J.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S106 - S106
  • [12] Comparison of low-dose TBI-Based reduced-intensity conditioning (RIC) vs. chemotherapy-based RIC prior to allogeneic stem cell transplantation from an HLA identical sibling donor for AML in first complete remission
    Mohty, M.
    Labopin, M.
    Janssen, J.
    Mufti, G.
    Cornelissen, J. J.
    Milpied, N.
    Sengeloev, H.
    Blaise, D.
    Petersen, E.
    Goker, H.
    Gribben, J.
    Nagler, A.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S38 - S39
  • [13] Risk Factors for Overall Survival in Patients with Acute Myeloid Leukemia (AML) with Normal Karyotype Undergoing Allogeneic Stem Cell Transplantation (allo-SCT) in First Complete Remission (CR1): A Report On 366 Patients From the Acute Leukemia Working Party of EBMT
    Schmid, Christoph
    Labopin, Myriam
    Deconinck, Eric
    Attal, Michel
    Socie, Gerard
    Vigouroux, Stephane
    Volin, Liisa
    Ifrah, Norbert
    Rambaldi, Alessandro
    Rossi, Jean-Francois
    Blaise, Didier
    Cornelissen, Jan
    Ljungman, Per T.
    Brune, Mats L.
    Bordigoni, Pierre
    Vernant, Jean-Paul
    Yakoub-Agha, Ibrahim
    Pogliani, Enrico Maria
    Michallet, Mauricette
    Arcese, William
    Polge, Emmanuelle
    Esteve, Jordi
    Mohty, Mohamad
    BLOOD, 2012, 120 (21)
  • [14] Busulfan (Bu) Plus Cyclophosphamide (Cy) Versus TBI Plus Cy Conditioning for Allogeneic Stem Cell Transplantation (alloSCT) From Matched Unrelated Donors (MUD) In Adult Patients with AML in First Relapse: A Survey From the Acute Leukemia Working Party of EBMT
    Nagler, Arnon
    Labopin, Myriam
    Shimoni, Avichai
    Finke, Juergen
    Beelen, Dietrich
    Volin, Liisa
    Passweg, Jakob R.
    Schwerdtfeger, Rainer
    Kolb, Hans-Jochem
    Anagnostopoulos, Achilles
    Rocha, Vanderson
    Ciceri, Fabio
    Mohty, Mohamad
    BLOOD, 2011, 118 (21) : 79 - 80
  • [15] Thiotepa-Based Vs TBI-Based Myeloablative Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myeloid Leukemia (AML) In First Complete Re ission (CR1): A Retrospective Analysis From The ALWP Of The EBMT
    Eder, Sandra
    Labopin, Myriam
    Arcese, William
    Or, Reuven
    Majolino, Ignazio
    Bacigalupo, Andrea
    de Rosa, Gennaro
    Volin, Liisa
    Beelen, Dietrich
    Veelken, Hendrik
    Schaap, Nicolaas P. M.
    Kuball, Jurgen H.
    Cornelissen, Jan
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2013, 122 (21)
  • [16] Association Between the Hematopoietic Cell Transplantation-Specific Comorbidity Index (CI) and Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
    Mohty, Mohamad
    Labopin, Myriam
    Basara, Nadezda
    Cornelissen, Jan J.
    Tabrizi, Reza
    Malm, Claes
    Perez Simon, Jose Antonio
    Nagler, Arnon
    Kroger, Nicolaus
    Rio, Bernard
    Martino, Rodrigo
    Eder, Matthias
    Bilger, Karin
    Bunjes, Donald W.
    Socie, Gerard
    Blaise, Didier
    Polge, Emmanuelle
    Rocha, Vanderson
    BLOOD, 2009, 114 (22) : 270 - 270
  • [17] ASSOCIATION BETWEEN THE HEMATOPOIETIC CELL TRANSPLANTATION-SPECIFIC COMORBIDITY INDEX (CIN) AND NON-RELAPSE MORTALITY (NRM) AFTER REDUCED INTENSITY CONDITIONING (RIC) ALLOGENEIC STEM CELL TRANSPLANTATION (ALLO-SCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1)
    Mohty, M.
    Labopin, M.
    Basara, N.
    Cornelissen, J.
    Tabrizi, R.
    Malm, C.
    Perez-Simon, J. A.
    Nagler, A.
    Kroger, N.
    Rio, B.
    Martino, R.
    Eder, M.
    Bilger, K.
    Bunjes, D. W.
    Socie, G.
    Blaise, D.
    Polge, E.
    Rocha, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S281 - S281
  • [18] Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
    Baron, F.
    Labopin, M.
    Blaise, D.
    Lopez-Corral, L.
    Vigouroux, S.
    Craddock, C.
    Attal, M.
    Jindra, P.
    Goker, H.
    Socie, G.
    Chevallier, P.
    Browne, P.
    Sandstedt, A.
    Duarte, R. F.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 (03) : 389 - 396
  • [19] Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation
    F Baron
    M Labopin
    D Blaise
    L Lopez-Corral
    S Vigouroux
    C Craddock
    M Attal
    P Jindra
    H Goker
    G Socié
    P Chevallier
    P Browne
    A Sandstedt
    R F Duarte
    A Nagler
    M Mohty
    Bone Marrow Transplantation, 2014, 49 : 389 - 396
  • [20] Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
    Eder, Sandra
    Labopin, Myriam
    Arcese, William
    Or, Reuven
    Majolino, Ignazio
    Bacigalupo, Andrea
    de Rosa, Gennaro
    Volin, Liisa
    Beelen, Dietrich
    Veelken, Hendrik
    Schaap, Nicolaas P. M.
    Kuball, Jurgen
    Cornelissen, Jan
    Nagler, Arnon
    Mohty, Mohamad
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 90 - 97
123